| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 2.29e-11 | 10 | 141 | 6 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 2.29e-11 | 10 | 141 | 6 | GO:0102033 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 3.39e-10 | 7 | 141 | 5 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 3.39e-10 | 7 | 141 | 5 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 4.00e-09 | 10 | 141 | 5 | GO:0052869 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.01e-08 | 13 | 141 | 5 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 6.24e-07 | 24 | 141 | 5 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.16e-06 | 27 | 141 | 5 | GO:0008391 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.21e-06 | 49 | 141 | 6 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate binding | 3.06e-06 | 15 | 141 | 4 | GO:0050544 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 3.41e-06 | 5 | 141 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | icosanoid binding | 4.06e-06 | 16 | 141 | 4 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 4.06e-06 | 16 | 141 | 4 | GO:0050543 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.48e-06 | 35 | 141 | 5 | GO:0070330 | |
| GeneOntologyMolecularFunction | heme binding | 1.39e-05 | 154 | 141 | 8 | GO:0020037 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.39e-05 | 111 | 141 | 7 | GO:0003727 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.19e-05 | 164 | 141 | 8 | GO:0046906 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 4.28e-05 | 28 | 141 | 4 | GO:0036041 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 4.95e-05 | 2 | 141 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 4.95e-05 | 2 | 141 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 4.95e-05 | 2 | 141 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 4.95e-05 | 2 | 141 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF13B ATP7B CCT7 MCM6 CHD2 SRCAP ABCA8 IGHMBP2 CARNS1 DDX24 HSP90AB1 HSP90AB3P | 7.08e-05 | 441 | 141 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | transition metal ion binding | CYP4V2 UBR2 EPRS1 ABO ATP7B CYP4A11 POLR2A UBR4 CYP4F2 GCH1 NR6A1 APP NSMCE2 CYP4A22 ZFHX4 IGHMBP2 CYP4F3 MMP3 MMP11 RNF207 CYP4F11 | 9.23e-05 | 1189 | 141 | 21 | GO:0046914 |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.67e-04 | 115 | 141 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF13B ATP7B MYH7B CCT7 MCM6 CHD2 SRCAP ABCA8 IGHMBP2 CARNS1 DDX24 HSP90AB1 HSP90AB3P | 4.19e-04 | 614 | 141 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.63e-04 | 194 | 141 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.17e-03 | 166 | 141 | 6 | GO:0005506 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.26e-03 | 230 | 141 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.35e-03 | 8 | 141 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | fatty acid binding | 1.44e-03 | 69 | 141 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.76e-03 | 34 | 141 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.15e-03 | 10 | 141 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.81e-03 | 40 | 141 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.81e-03 | 40 | 141 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.99e-03 | 138 | 141 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF13B ATP7B CCT7 MCM6 CHD2 GCH1 SRCAP ABCA8 IGHMBP2 CARNS1 DDX24 HSP90AB1 HSP90AB3P | 3.38e-03 | 775 | 141 | 13 | GO:0017111 |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.02e-08 | 6 | 140 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 7.00e-08 | 7 | 140 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 1.39e-07 | 8 | 140 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 6.47e-07 | 11 | 140 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 9.65e-07 | 12 | 140 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.93e-06 | 14 | 140 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 6.80e-06 | 68 | 140 | 6 | GO:0019369 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 1.35e-05 | 22 | 140 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | oxylipin metabolic process | 4.57e-05 | 2 | 140 | 2 | GO:0031407 | |
| GeneOntologyBiologicalProcess | oxylipin biosynthetic process | 4.57e-05 | 2 | 140 | 2 | GO:0031408 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 8.68e-05 | 266 | 140 | 9 | GO:0022898 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 1.37e-04 | 3 | 140 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | lauric acid metabolic process | 1.37e-04 | 3 | 140 | 2 | GO:0048252 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 1.52e-04 | 168 | 140 | 7 | GO:0000723 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.69e-04 | 41 | 140 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.03e-04 | 124 | 140 | 6 | GO:0001676 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 2.09e-04 | 299 | 140 | 9 | GO:0032409 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.42e-04 | 128 | 140 | 6 | GO:0033559 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 2.72e-04 | 4 | 140 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 2.72e-04 | 4 | 140 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 2.72e-04 | 4 | 140 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 2.72e-04 | 4 | 140 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 2.72e-04 | 4 | 140 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | lactation | 3.14e-04 | 48 | 140 | 4 | GO:0007595 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 3.68e-04 | 256 | 140 | 8 | GO:0032412 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 4.22e-04 | 142 | 140 | 6 | GO:0006690 | |
| GeneOntologyBiologicalProcess | telomere organization | 4.27e-04 | 199 | 140 | 7 | GO:0032200 | |
| GeneOntologyBiologicalProcess | fatty acid omega-oxidation | 4.51e-04 | 5 | 140 | 2 | GO:0010430 | |
| GeneOntologyCellularComponent | paranode region of axon | 1.87e-04 | 17 | 140 | 3 | GO:0033270 | |
| GeneOntologyCellularComponent | GAIT complex | 2.65e-04 | 4 | 140 | 2 | GO:0097452 | |
| GeneOntologyCellularComponent | main axon | 3.32e-04 | 89 | 140 | 5 | GO:0044304 | |
| Domain | Znf_CHHC | 4.03e-07 | 3 | 139 | 3 | IPR012996 | |
| Domain | zf-RNPHF | 4.03e-07 | 3 | 139 | 3 | PF08080 | |
| Domain | Cyt_P450_E_grp-I | 9.78e-07 | 45 | 139 | 6 | IPR002401 | |
| Domain | Cyt_P450_CS | 2.63e-06 | 53 | 139 | 6 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 4.05e-06 | 57 | 139 | 6 | PS00086 | |
| Domain | - | 4.49e-06 | 58 | 139 | 6 | 1.10.630.10 | |
| Domain | p450 | 4.49e-06 | 58 | 139 | 6 | PF00067 | |
| Domain | Cyt_P450 | 5.49e-06 | 60 | 139 | 6 | IPR001128 | |
| Domain | FAM184 | 5.50e-05 | 2 | 139 | 2 | IPR029605 | |
| Domain | FYrich_C | 5.42e-04 | 5 | 139 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.42e-04 | 5 | 139 | 2 | IPR003888 | |
| Domain | FYRC | 5.42e-04 | 5 | 139 | 2 | SM00542 | |
| Domain | FYRN | 5.42e-04 | 5 | 139 | 2 | SM00541 | |
| Domain | Cyt_B5_heme-BS | 5.42e-04 | 5 | 139 | 2 | IPR018506 | |
| Domain | MOEP19_KH-like | 5.42e-04 | 5 | 139 | 2 | IPR031952 | |
| Domain | FYRN | 5.42e-04 | 5 | 139 | 2 | PF05964 | |
| Domain | FYRC | 5.42e-04 | 5 | 139 | 2 | PF05965 | |
| Domain | FYRC | 5.42e-04 | 5 | 139 | 2 | PS51543 | |
| Domain | FYRN | 5.42e-04 | 5 | 139 | 2 | PS51542 | |
| Domain | MOEP19 | 5.42e-04 | 5 | 139 | 2 | PF16005 | |
| Pathway | REACTOME_EICOSANOIDS | 1.82e-08 | 12 | 108 | 5 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.82e-08 | 12 | 108 | 5 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 1.82e-08 | 12 | 108 | 5 | MM14845 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 2.19e-08 | 62 | 108 | 8 | M39653 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 4.56e-08 | 14 | 108 | 5 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 6.79e-08 | 15 | 108 | 5 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.90e-07 | 18 | 108 | 5 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.90e-07 | 18 | 108 | 5 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 4.44e-07 | 21 | 108 | 5 | M27137 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.03e-06 | 11 | 108 | 4 | MM14863 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.13e-06 | 25 | 108 | 5 | MM14858 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.28e-06 | 104 | 108 | 8 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.38e-06 | 105 | 108 | 8 | MM14842 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 4.81e-06 | 33 | 108 | 5 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 4.81e-06 | 33 | 108 | 5 | MM15963 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 5.70e-06 | 59 | 108 | 6 | M27140 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.93e-06 | 61 | 108 | 6 | MM14861 | |
| Pathway | BIOCARTA_PDZS_PATHWAY | 9.18e-06 | 18 | 108 | 4 | M22001 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.19e-06 | 64 | 108 | 6 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.10e-05 | 66 | 108 | 6 | MM14839 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 3.55e-05 | 9 | 108 | 3 | M39819 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.77e-04 | 219 | 108 | 8 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.86e-04 | 220 | 108 | 8 | M10320 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 3.19e-04 | 43 | 108 | 4 | MM15873 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 6.93e-04 | 23 | 108 | 3 | M41723 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 1.01e-03 | 58 | 108 | 4 | M5410 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 1.07e-03 | 59 | 108 | 4 | M48104 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 1.12e-03 | 27 | 108 | 3 | M27632 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA1 EPRS1 ILF3 CASP14 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 PFAS MCM6 CHD2 SRCAP NCAPH HNRNPF HNRNPH1 HNRNPH2 TGM3 PCGF6 FXR1 RBM8A PRPF38A DDX24 WDR13 SYNCRIP KPNA1 HSP90AB1 | 7.56e-12 | 1353 | 142 | 27 | 29467282 |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | ILF3 SPTAN1 SPTBN1 CCT7 HNRNPF HNRNPH1 HNRNPH2 FXR1 LSM10 SYNCRIP | 5.51e-10 | 147 | 142 | 10 | 28977470 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 ILF3 CASP14 SPTAN1 SPTBN1 CCT7 PFAS MCM6 DBN1 HNRNPH1 HNRNPH2 TGM3 FXR1 SYNCRIP HSP90AB1 | 1.28e-09 | 477 | 142 | 15 | 31300519 |
| Pubmed | CASP14 SPTAN1 SPTBN1 UBR4 DBN1 HNRNPF HNRNPH1 HNRNPH2 TGM3 PCGF6 KPNA1 HSP90AB1 | 1.45e-09 | 272 | 142 | 12 | 31010829 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 EPS15 STRN3 ILF3 ANK3 SPTAN1 SPTBN1 UBR4 CCT7 PFAS MCM6 DBN1 NCAPH MBD3 HNRNPF HNRNPH1 TTLL12 FXR1 RBM8A SYNCRIP KPNA1 HSP90AB1 | 1.78e-09 | 1149 | 142 | 22 | 35446349 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ILF3 POLR2A CCT7 MCM6 SRCAP HNRNPF HNRNPH1 HNRNPH2 MAP3K4 PPP4R3B FXR1 CAMSAP1 EIF2AK3 KPNA1 | 4.04e-09 | 440 | 142 | 14 | 34244565 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIF13B ILF3 POLR2A UBR4 PFAS MCM6 NCAPH HNRNPF MSTO1 HNRNPH1 HNRNPH2 MAP3K4 FXR1 TIMELESS PRPF38A DDX24 KPNA1 | 5.10e-09 | 704 | 142 | 17 | 29955894 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | MAGEA1 EPRS1 ILF3 SPTAN1 POLR2A CCT7 MCM6 DBN1 HNRNPF HNRNPH1 HNRNPH2 FXR1 RBM8A PRPF38A DDX24 SYNCRIP HSP90AB1 | 6.28e-09 | 714 | 142 | 17 | 28302793 |
| Pubmed | EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 PFAS DBN1 HNRNPF STX1B HNRNPH1 HNRNPH2 GUK1 FAM169A SYNCRIP HSP90AB1 | 9.11e-09 | 552 | 142 | 15 | 36293380 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 EPS15 FAM193B STRN3 ILF3 POLR2A CCT7 PFAS DBN1 SRCAP NCAPH SNX29 HNRNPF PDCD4 HNRNPH1 FAM169A CAMSAP1 PCNT HSP90AB1 | 9.67e-09 | 934 | 142 | 19 | 33916271 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 SPTAN1 POLR2A SPTBN1 UBR4 SRCAP PDCD4 HNRNPH2 TTLL12 UMPS SYNCRIP HSP90AB1 | 1.35e-08 | 332 | 142 | 12 | 32786267 |
| Pubmed | ILF3 SPTAN1 SPTBN1 UBR4 HNRNPF HNRNPH1 HNRNPH2 DDX24 SYNCRIP KPNA1 | 1.44e-08 | 206 | 142 | 10 | 22174317 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NWD1 ANK3 POLR2A SPTBN1 CHD2 PARVG DYSF RYR3 MAP3K4 STAT5A KMT2C IGHMBP2 HERC1 DDX24 | 1.87e-08 | 497 | 142 | 14 | 36774506 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 STRN3 ILF3 SPTAN1 POLR2A SPTBN1 DBN1 MIER1 HNRNPF HNRNPH1 KMT2D TJAP1 TIMELESS RBM8A PRPF38A DDX24 HSP90AB1 | 2.05e-08 | 774 | 142 | 17 | 15302935 |
| Pubmed | UBR2 EPRS1 ILF3 SPTAN1 POLR2A SPTBN1 CCT7 PFAS MCM6 APP LANCL2 HNRNPF PDCD4 HNRNPH1 FXR1 IGHMBP2 RBM8A DDX24 SYNCRIP TJP3 HSP90AB1 | 3.93e-08 | 1247 | 142 | 21 | 27684187 | |
| Pubmed | ILF3 DBN1 MAST2 KMT2D FXR1 UMPS HERC1 CAMSAP1 DDX24 HSP90AB1 | 4.80e-08 | 234 | 142 | 10 | 36243803 | |
| Pubmed | EPRS1 ILF3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 MCM6 HNRNPF HNRNPH1 TTLL12 FXR1 UMPS SYNCRIP HSP90AB1 | 6.10e-08 | 638 | 142 | 15 | 33239621 | |
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 6.66e-08 | 3 | 142 | 3 | 15145985 | |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 14980514 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 7499401 | ||
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 10456323 | ||
| Pubmed | EPRS1 ILF3 SPTAN1 SPTBN1 UBR4 CCT7 DBN1 HNRNPF PDCD4 HNRNPH1 HNRNPH2 FXR1 SYNCRIP HSP90AB1 | 6.69e-08 | 551 | 142 | 14 | 34728620 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 ILF3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 PFAS MCM6 NCAPH LANCL2 MBD3 HNRNPF PDCD4 HNRNPH1 HNRNPH2 FXR1 RBM8A DDX24 SYNCRIP KPNA1 HSP90AB1 | 7.31e-08 | 1415 | 142 | 22 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 ILF3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 PFAS MCM6 DBN1 MAST2 NCAPH LANCL2 MBD3 HNRNPF HNRNPH1 TTLL12 TGM3 FXR1 DDX24 SYNCRIP HSP90AB1 | 8.26e-08 | 1425 | 142 | 22 | 30948266 |
| Pubmed | SLC12A6 KIF13B EPRS1 FAM184B STRN3 ILF3 MYH7B SPTAN1 SPTBN1 UBR4 CHD2 DBN1 SRCAP NCAPH HNRNPF CYB5B FXR1 NRXN3 FAM169A SYNCRIP PCNT HSP90AB1 | 1.01e-07 | 1442 | 142 | 22 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 EPS15 STRN3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 PFAS MCM6 GFUS NCAPH HNRNPF PDCD4 HNRNPH1 TTLL12 PPP4R3B TIMELESS HERC1 SYNCRIP KPNA1 HSP90AB1 | 1.18e-07 | 1455 | 142 | 22 | 22863883 |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 1.27e-07 | 57 | 142 | 6 | 17932509 | |
| Pubmed | EPRS1 STRN3 POLR2A CCT7 DBN1 NCAPH MBD3 HNRNPF HNRNPH1 HNRNPH2 SYNCRIP HSP90AB1 | 1.38e-07 | 411 | 142 | 12 | 36652389 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CYP4V2 SLC12A6 UBR2 EPS15 ANK3 NCAM2 CHD2 RILPL1 APP NSMCE2 SNX29 HNRNPF KMT2C EXOC6B TJAP1 AADAT WDR13 CYP4F11 SCARA3 CYB5A KPNA1 PCNT | 1.76e-07 | 1489 | 142 | 22 | 28611215 |
| Pubmed | EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 PFAS HNRNPF HNRNPH1 TGM3 SYNCRIP | 1.88e-07 | 271 | 142 | 10 | 26816005 | |
| Pubmed | EPRS1 ILF3 SPTAN1 SPTBN1 DBN1 HNRNPF HNRNPH1 FXR1 SYNCRIP HSP90AB1 | 2.08e-07 | 274 | 142 | 10 | 34244482 | |
| Pubmed | EPRS1 ILF3 SPTAN1 SPTBN1 UBR4 CCT7 HNRNPF HNRNPH1 HNRNPH2 TTLL12 KMT2C KMT2D FXR1 SYNCRIP HSP90AB1 | 2.45e-07 | 711 | 142 | 15 | 33022573 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 2.66e-07 | 4 | 142 | 3 | 18065749 | |
| Pubmed | 2.66e-07 | 4 | 142 | 3 | 10660572 | ||
| Pubmed | EPRS1 ANK3 SPTAN1 SPTBN1 UBR4 NCAM2 CCT7 RILPL1 HUNK APP HNRNPF MSTO1 RYR3 TTLL12 PPP4R3B GUK1 WDR13 KPNA1 PCNT HSP90AB1 | 3.01e-07 | 1285 | 142 | 20 | 35914814 | |
| Pubmed | EPRS1 EPS15 ILF3 ATP7B UBR4 NCAPH HNRNPF HNRNPH1 HNRNPH2 CYB5B FXR1 IGHMBP2 ITPRIP DDX24 EIF2AK3 CYB5A SYNCRIP PCNT HSP90AB1 | 3.15e-07 | 1168 | 142 | 19 | 19946888 | |
| Pubmed | CPNE9 ILF3 CASP14 ANK3 UBR4 CCT7 MCM6 DBN1 LANCL2 HNRNPF HNRNPH1 HNRNPH2 TGM3 SYNCRIP KPNA1 HSP90AB1 | 3.97e-07 | 844 | 142 | 16 | 25963833 | |
| Pubmed | 4.41e-07 | 70 | 142 | 6 | 15128046 | ||
| Pubmed | KIF13B EPRS1 FAM184B ANK3 SPTBN1 CHD2 SRCAP LANCL2 MIER1 HNRNPF KMT2C FXR1 ITPRIP TIMELESS PRPF38A HERC1 CPLANE1 PCNT | 4.92e-07 | 1084 | 142 | 18 | 11544199 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 5.08e-07 | 169 | 142 | 8 | 23084401 | |
| Pubmed | SPTAN1 POLR2A SPTBN1 UBR4 PFAS MCM6 CHD2 HNRNPF TTLL12 TGM3 FXR1 DDX24 SYNCRIP PCNT | 5.20e-07 | 653 | 142 | 14 | 22586326 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | EPRS1 STRN3 SPTAN1 SPTBN1 DBN1 ABCA8 HNRNPF HNRNPH1 HNRNPH2 GUK1 EXOC6B CPLANE1 HSP90AB1 | 6.05e-07 | 564 | 142 | 13 | 21565611 |
| Pubmed | UBR2 ILF3 SPTAN1 POLR2A MCM6 SRCAP HNRNPH1 HNRNPH2 SYNCRIP KPNA1 HSP90AB1 | 6.58e-07 | 390 | 142 | 11 | 17643375 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 6.62e-07 | 175 | 142 | 8 | 25756610 | |
| Pubmed | ILF3 SPTAN1 SPTBN1 HNRNPF HNRNPH1 HNRNPH2 SYNCRIP HSP90AB1 HSP90AB3P | 6.64e-07 | 239 | 142 | 9 | 23246001 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPRS1 SPTAN1 SPTBN1 MCM6 CHD2 DBN1 SRCAP NCAPH DDX24 SYNCRIP KPNA1 | 7.27e-07 | 394 | 142 | 11 | 27248496 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | ILF3 SPTAN1 MCM6 HNRNPF HNRNPH1 PCGF6 FXR1 IGHMBP2 DDX24 SYNCRIP | 7.67e-07 | 316 | 142 | 10 | 31665637 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 DBN1 NCAPH LANCL2 HNRNPF PDCD4 HNRNPH1 HNRNPH2 TGM3 FXR1 RBM8A DDX24 SYNCRIP KPNA1 HSP90AB1 | 9.46e-07 | 1257 | 142 | 19 | 36526897 |
| Pubmed | UBR2 EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 MCM6 HNRNPF HNRNPH1 HNRNPH2 SYNCRIP HSP90AB1 | 9.69e-07 | 494 | 142 | 12 | 26831064 | |
| Pubmed | EPRS1 EPS15 STRN3 ILF3 MCM6 NCAPH PDCD4 PPP4R3B TIMELESS RBM8A DDX24 HSP90AB1 | 1.17e-06 | 503 | 142 | 12 | 16964243 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | ILF3 CCT7 DBN1 HNRNPF PDCD4 MSTO1 HNRNPH1 HNRNPH2 PCGF6 YJU2B UMPS SYNCRIP KPNA1 HSP90AB1 | 1.26e-06 | 704 | 142 | 14 | 32994395 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | EPRS1 ILF3 CASP14 SPTBN1 MCM6 MBD3 HNRNPF HNRNPH1 ZFHX4 DDX24 SYNCRIP KPNA1 HSP90AB1 | 1.32e-06 | 605 | 142 | 13 | 28977666 |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 9068972 | ||
| Pubmed | EPRS1 EPS15 ILF3 SPTBN1 UBR4 CCT7 MCM6 DBN1 HNRNPF HNRNPH1 HNRNPH2 TTLL12 SYNCRIP HSP90AB1 | 1.33e-06 | 707 | 142 | 14 | 19738201 | |
| Pubmed | EPRS1 EPS15 ILF3 ANK3 SPTBN1 CCT7 LANCL2 HNRNPF HNRNPH1 CRYBG3 CAMSAP1 EIF2AK3 SYNCRIP HSP90AB1 | 1.35e-06 | 708 | 142 | 14 | 39231216 | |
| Pubmed | UBR2 ANK3 SPTAN1 POLR2A SPTBN1 CCT7 PFAS APP PPP4R3B CNNM1 KMT2D PRPF38A CRYBG3 HERC1 KPNA1 PCNT HSP90AB1 | 1.46e-06 | 1049 | 142 | 17 | 27880917 | |
| Pubmed | 1.49e-06 | 195 | 142 | 8 | 19454010 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 1.61e-06 | 197 | 142 | 8 | 22365833 | |
| Pubmed | EPRS1 ILF3 POLR2A CCT7 MCM6 HNRNPF MSTO1 HNRNPH1 HNRNPH2 FXR1 UMPS RBM8A SYNCRIP HSP90AB1 | 1.78e-06 | 725 | 142 | 14 | 27025967 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 1.80e-06 | 200 | 142 | 8 | 35546148 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 ILF3 UBR4 MCM6 CHD2 NCAPH HNRNPF PDCD4 HNRNPH1 HNRNPH2 STAT5A PPP4R3B FXR1 RBM8A PRPF38A DDX24 SYNCRIP KPNA1 HSP90AB1 | 1.90e-06 | 1318 | 142 | 19 | 30463901 |
| Pubmed | KIF13B EPS15 STRN3 ILF3 ANK3 SPTAN1 SPTBN1 UBR4 DBN1 MBD3 FXR1 TJAP1 CAMSAP1 KPNA1 PCNT HSP90AB1 | 2.21e-06 | 963 | 142 | 16 | 28671696 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 2.59e-06 | 210 | 142 | 8 | 26217791 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B POLR2A UBR4 PFAS SRCAP DYSF MAST2 MBD3 KMT2C KMT2D POLL HERC1 CAMSAP1 LSM10 SCARA3 PCNT TJP3 | 2.93e-06 | 1105 | 142 | 17 | 35748872 |
| Pubmed | 3.09e-06 | 215 | 142 | 8 | 30462309 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | EPRS1 ILF3 CASP14 SPTAN1 SPTBN1 CCT7 HNRNPF HNRNPH1 HNRNPH2 TGM3 SYNCRIP HSP90AB1 | 3.40e-06 | 558 | 142 | 12 | 27591049 |
| Pubmed | ILF3 SPTAN1 CCT7 MCM6 DBN1 HNRNPF HNRNPH1 TTLL12 FXR1 SYNCRIP HSP90AB1 | 3.45e-06 | 463 | 142 | 11 | 34901782 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP17L7 KIF13B STRN3 CASP14 CCT7 PFAS MCM6 GCH1 LANCL2 PDCD4 TGM3 UMPS RBM8A DDX24 KLHL18 KPNA1 | 3.80e-06 | 1005 | 142 | 16 | 19615732 |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 4.18e-06 | 224 | 142 | 8 | 28443643 | |
| Pubmed | EPRS1 STRN3 ANK3 SPTAN1 SPTBN1 UBR4 CCT7 DBN1 APP STX1B HNRNPH2 IGHMBP2 FAM169A CRYBG3 CAMSAP1 CYB5A HSP90AB1 | 4.38e-06 | 1139 | 142 | 17 | 36417873 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 4.55e-06 | 104 | 142 | 6 | 36055981 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 ILF3 CASP14 POLR2A CCT7 MCM6 APP SRCAP HNRNPF HNRNPH1 HNRNPH2 FXR1 RBM8A SYNCRIP PCNT HSP90AB1 | 4.82e-06 | 1024 | 142 | 16 | 24711643 |
| Pubmed | 4.91e-06 | 305 | 142 | 9 | 33194618 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ILF3 SPTAN1 SPTBN1 CCT7 NCAPH HNRNPF HNRNPH1 UMPS SYNCRIP KPNA1 PCNT HSP90AB1 | 5.21e-06 | 582 | 142 | 12 | 20467437 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 5.41e-06 | 232 | 142 | 8 | 25515538 | |
| Pubmed | 5.90e-06 | 312 | 142 | 9 | 37120454 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 5.94e-06 | 235 | 142 | 8 | 28378594 | |
| Pubmed | 5.97e-06 | 109 | 142 | 6 | 29511296 | ||
| Pubmed | EPRS1 EPS15 ILF3 UBR4 CCT7 MCM6 HNRNPF HNRNPH1 TTLL12 SYNCRIP HSP90AB1 | 6.02e-06 | 491 | 142 | 11 | 22623428 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 ILF3 ANK3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 SRCAP HNRNPF HNRNPH1 RBM8A SYNCRIP HSP90AB1 | 6.08e-06 | 807 | 142 | 14 | 30575818 |
| Pubmed | 6.14e-06 | 63 | 142 | 5 | 37052853 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 6.73e-06 | 170 | 142 | 7 | 16159877 | |
| Pubmed | 7.23e-06 | 320 | 142 | 9 | 28685749 | ||
| Pubmed | 7.26e-06 | 172 | 142 | 7 | 23184937 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 7.69e-06 | 31 | 142 | 4 | 20516061 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 7.83e-06 | 10 | 142 | 3 | 22159418 | |
| Pubmed | 8.60e-06 | 327 | 142 | 9 | 31409639 | ||
| Pubmed | EPRS1 ILF3 CASP14 SPTAN1 CCT7 HNRNPF HNRNPH1 TGM3 SYNCRIP HSP90AB1 | 9.17e-06 | 418 | 142 | 10 | 35338135 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 9.25e-06 | 330 | 142 | 9 | 33301849 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ILF3 SPTAN1 POLR2A SPTBN1 CHD2 DBN1 SRCAP MBD3 HNRNPF HNRNPH1 HNRNPH2 RBM8A PRPF38A DDX24 SYNCRIP HSP90AB1 | 9.58e-06 | 1082 | 142 | 16 | 38697112 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SLC12A6 STX2 EPRS1 SPTAN1 SPTBN1 CCT7 DBN1 LANCL2 STX1B HNRNPH1 SYNCRIP HSP90AB1 | 9.99e-06 | 621 | 142 | 12 | 22794259 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 MCM6 SRCAP NCAPH HNRNPH1 PPP4R3B KPNA1 PCNT HSP90AB1 HSP90AB3P | 1.05e-05 | 847 | 142 | 14 | 35235311 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | CASP14 SPTBN1 CCT7 MCM6 DBN1 HNRNPF HNRNPH1 HNRNPH2 FXR1 DDX24 KPNA1 HSP90AB1 | 1.05e-05 | 624 | 142 | 12 | 33729478 |
| Pubmed | EPRS1 ILF3 SPTAN1 CCT7 MCM6 HNRNPF HNRNPH1 HNRNPH2 SYNCRIP HSP90AB1 | 1.06e-05 | 425 | 142 | 10 | 21081503 | |
| Pubmed | 1.07e-05 | 11 | 142 | 3 | 21900255 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 CACNA1F EPRS1 POLR2A UBR4 CHD2 PARVG HNRNPF HNRNPH1 TTLL12 ZFYVE28 KMT2C HSP90AB1 | 1.10e-05 | 736 | 142 | 13 | 29676528 |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.17e-05 | 258 | 142 | 8 | 21081666 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UBR2 POLR2A UBR4 MCM6 NCAPH PCGF6 KMT2D FXR1 ZFHX4 CAMSAP1 DDX24 EIF2AK3 KPNA1 HSP90AB1 | 1.19e-05 | 857 | 142 | 14 | 25609649 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.21e-05 | 259 | 142 | 8 | 30404004 | |
| Pubmed | UBR2 ILF3 CASP14 ANK3 POLR2A UBR4 CYB5B FXR1 UMPS DDX24 SYNCRIP KPNA1 | 1.23e-05 | 634 | 142 | 12 | 34591612 | |
| Interaction | ERG interactions | ILF3 SPTAN1 POLR2A UBR4 DBN1 APP HNRNPF HNRNPH1 KMT2C KMT2D ZFHX4 WDR13 | 4.86e-08 | 223 | 139 | 12 | int:ERG |
| Interaction | C1orf87 interactions | 2.70e-07 | 21 | 139 | 5 | int:C1orf87 | |
| Interaction | SUMO2 interactions | EPRS1 SPTAN1 POLR2A SPTBN1 UBR4 SRCAP MAST2 ABCA8 HNRNPF PDCD4 HNRNPH1 HNRNPH2 TTLL12 UMPS RBM8A SYNCRIP HSP90AB1 | 6.93e-07 | 591 | 139 | 17 | int:SUMO2 |
| Interaction | COPS5 interactions | EPRS1 STRN3 ILF3 TMC1 SPTAN1 POLR2A SPTBN1 UBR4 PFAS MCM6 HUNK APP HNRNPF HNRNPH1 HNRNPH2 FXR1 CFAP58 RBM8A EIF2AK3 KLHL18 SYNCRIP KPNA1 HSP90AB1 | 1.86e-06 | 1102 | 139 | 23 | int:COPS5 |
| Interaction | DUX4 interactions | EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 PFAS HNRNPF HNRNPH1 TGM3 SYNCRIP | 2.39e-06 | 214 | 139 | 10 | int:DUX4 |
| Interaction | CYP4A11 interactions | 3.18e-06 | 5 | 139 | 3 | int:CYP4A11 | |
| Interaction | USP48 interactions | EPRS1 ILF3 SPTAN1 SPTBN1 CCT7 PFAS DBN1 APP HNRNPF STX1B HNRNPH1 HNRNPH2 GUK1 FAM169A TIMELESS SYNCRIP HSP90AB1 | 3.65e-06 | 668 | 139 | 17 | int:USP48 |
| Interaction | SOX2 interactions | EPRS1 ILF3 SPTAN1 SPTBN1 UBR4 CCT7 DBN1 GFUS MAST2 MIER1 MBD3 HNRNPF HNRNPH1 HNRNPH2 CHRNB2 KMT2C KMT2D ZFHX4 YJU2B RBM8A CPLANE1 DDX24 CYB5A PCNT HSP90AB1 HSP90AB3P | 4.17e-06 | 1422 | 139 | 26 | int:SOX2 |
| Interaction | AGO1 interactions | 5.13e-06 | 183 | 139 | 9 | int:AGO1 | |
| Interaction | WDR77 interactions | ILF3 SPTAN1 SPTBN1 CCT7 HNRNPF PDCD4 HNRNPH1 HNRNPH2 FXR1 TIMELESS LSM10 SYNCRIP | 7.89e-06 | 361 | 139 | 12 | int:WDR77 |
| Interaction | BAP1 interactions | EPRS1 EPS15 STRN3 ILF3 ANK3 SPTAN1 SPTBN1 UBR4 CCT7 PFAS MCM6 DBN1 NCAPH LANCL2 MBD3 HNRNPF HNRNPH1 TTLL12 KMT2C FXR1 RBM8A SYNCRIP KPNA1 HSP90AB1 | 1.06e-05 | 1314 | 139 | 24 | int:BAP1 |
| Interaction | SGK2 interactions | 1.13e-05 | 43 | 139 | 5 | int:SGK2 | |
| Interaction | MIR20A interactions | 1.22e-05 | 74 | 139 | 6 | int:MIR20A | |
| Interaction | MAGOH interactions | ILF3 SPTAN1 SPTBN1 DBN1 HNRNPF HNRNPH1 HNRNPH2 FXR1 RBM8A SYNCRIP | 1.52e-05 | 264 | 139 | 10 | int:MAGOH |
| Interaction | EED interactions | EPRS1 ILF3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 MCM6 CHD2 DBN1 MBD3 HNRNPF HNRNPH1 HNRNPH2 TTLL12 PCGF6 FXR1 UMPS RBM8A PRPF38A DDX24 SYNCRIP KPNA1 PCNT HSP90AB1 | 1.70e-05 | 1445 | 139 | 25 | int:EED |
| Interaction | WASH2P interactions | 1.75e-05 | 8 | 139 | 3 | int:WASH2P | |
| Interaction | PINK1 interactions | EPRS1 ILF3 CASP14 SPTAN1 SPTBN1 CCT7 PFAS MCM6 DBN1 HNRNPH1 HNRNPH2 TGM3 FXR1 SYNCRIP HSP90AB1 HSP90AB3P | 1.86e-05 | 679 | 139 | 16 | int:PINK1 |
| Interaction | MCC interactions | 1.87e-05 | 215 | 139 | 9 | int:MCC | |
| Interaction | FBXO22 interactions | NWD1 ANK3 POLR2A SPTBN1 CHD2 PARVG DYSF RYR3 MAP3K4 STAT5A KMT2C IGHMBP2 HERC1 DDX24 | 2.27e-05 | 540 | 139 | 14 | int:FBXO22 |
| Interaction | TRIM28 interactions | KIF13B ILF3 SPTAN1 POLR2A UBR4 CCT7 PFAS MCM6 SRCAP NCAPH GRAMD4 HNRNPF MSTO1 HNRNPH1 HNRNPH2 MAP3K4 TTLL12 PPP4R3B PCGF6 FXR1 TIMELESS ZNF81 PRPF38A DDX24 KPNA1 | 2.37e-05 | 1474 | 139 | 25 | int:TRIM28 |
| Interaction | H2BC3 interactions | EPRS1 SPTAN1 SPTBN1 MCM6 APP SRCAP NCAPH KMT2C KMT2D DDX24 SYNCRIP KPNA1 | 2.53e-05 | 406 | 139 | 12 | int:H2BC3 |
| Interaction | SIRT6 interactions | ILF3 POLR2A CCT7 MCM6 SRCAP HNRNPF HNRNPH1 HNRNPH2 MAP3K4 PPP4R3B FXR1 CAMSAP1 EIF2AK3 SYNCRIP KPNA1 | 2.96e-05 | 628 | 139 | 15 | int:SIRT6 |
| Interaction | H2BC1 interactions | 3.33e-05 | 178 | 139 | 8 | int:H2BC1 | |
| Interaction | IVNS1ABP interactions | 3.61e-05 | 180 | 139 | 8 | int:IVNS1ABP | |
| Interaction | MIR128-1 interactions | 4.23e-05 | 92 | 139 | 6 | int:MIR128-1 | |
| Interaction | NAA40 interactions | EPRS1 EPS15 FAM193B STRN3 ILF3 POLR2A CCT7 PFAS DBN1 SRCAP NCAPH SNX29 HNRNPF PDCD4 HNRNPH1 FAM169A CAMSAP1 PCNT HSP90AB1 | 4.31e-05 | 978 | 139 | 19 | int:NAA40 |
| Interaction | MAU2 interactions | 4.44e-05 | 136 | 139 | 7 | int:MAU2 | |
| Interaction | H2AC4 interactions | EPRS1 SPTAN1 SPTBN1 MCM6 CHD2 DBN1 NCAPH MIER1 KMT2C KMT2D TIMELESS DDX24 SYNCRIP | 4.95e-05 | 506 | 139 | 13 | int:H2AC4 |
| Interaction | ZNF598 interactions | EPRS1 CASP14 SPTAN1 SPTBN1 CCT7 DBN1 NCAPH HNRNPH1 TGM3 FXR1 SYNCRIP HSP90AB1 | 4.95e-05 | 435 | 139 | 12 | int:ZNF598 |
| Interaction | OTUD7A interactions | 4.96e-05 | 58 | 139 | 5 | int:OTUD7A | |
| Interaction | NCBP2 interactions | 5.59e-05 | 141 | 139 | 7 | int:NCBP2 | |
| Interaction | AIRE interactions | 5.71e-05 | 97 | 139 | 6 | int:AIRE | |
| Interaction | GLDC interactions | EPRS1 ILF3 SPTAN1 SPTBN1 DBN1 HNRNPF HNRNPH1 FXR1 SYNCRIP HSP90AB1 | 7.94e-05 | 321 | 139 | 10 | int:GLDC |
| Interaction | RBM45 interactions | 9.65e-05 | 207 | 139 | 8 | int:RBM45 | |
| Interaction | MIRLET7A1 interactions | 1.04e-04 | 108 | 139 | 6 | int:MIRLET7A1 | |
| Interaction | KCNA3 interactions | EPRS1 EPS15 ILF3 ANK3 MYH7B SPTBN1 CCT7 CHD2 LANCL2 HNRNPF HNRNPH1 KMT2C CRYBG3 CAMSAP1 EIF2AK3 SYNCRIP HSP90AB1 | 1.06e-04 | 871 | 139 | 17 | int:KCNA3 |
| Interaction | MIR138-1 interactions | 1.07e-04 | 68 | 139 | 5 | int:MIR138-1 | |
| Interaction | FBXW11 interactions | EPRS1 FAM193B ILF3 PFAS APP MAST2 HNRNPF PDCD4 HNRNPH1 HNRNPH2 SYNCRIP KPNA1 | 1.10e-04 | 473 | 139 | 12 | int:FBXW11 |
| Interaction | UBASH3B interactions | 1.10e-04 | 157 | 139 | 7 | int:UBASH3B | |
| Interaction | LFNG interactions | 1.11e-04 | 14 | 139 | 3 | int:LFNG | |
| Interaction | PCDHA7 interactions | 1.11e-04 | 14 | 139 | 3 | int:PCDHA7 | |
| Interaction | MIR9-3 interactions | 1.23e-04 | 70 | 139 | 5 | int:MIR9-3 | |
| Interaction | DCUN1D1 interactions | ILF3 POLR2A HNRNPF HNRNPH1 HNRNPH2 POLL KLHL18 SYNCRIP HSP90AB1 | 1.26e-04 | 275 | 139 | 9 | int:DCUN1D1 |
| Interaction | SRPK2 interactions | ILF3 ANK3 POLR2A UBR4 CHD2 APP MAST2 HNRNPH2 FXR1 ZFHX4 RBM8A PRPF38A CAMSAP1 CPLANE1 DDX24 | 1.31e-04 | 717 | 139 | 15 | int:SRPK2 |
| Interaction | MIR140 interactions | 1.31e-04 | 71 | 139 | 5 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.31e-04 | 71 | 139 | 5 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 1.31e-04 | 71 | 139 | 5 | int:MIR29B2 | |
| Interaction | METTL14 interactions | ILF3 CASP14 SPTAN1 SPTBN1 CCT7 MCM6 HNRNPF PDCD4 HNRNPH1 RYR3 HERC1 SYNCRIP HSP90AB1 | 1.32e-04 | 558 | 139 | 13 | int:METTL14 |
| Interaction | CRY1 interactions | 1.34e-04 | 162 | 139 | 7 | int:CRY1 | |
| Interaction | HNRNPD interactions | EPRS1 ILF3 POLR2A DYSF HNRNPF HNRNPH1 HNRNPH2 MAP3K4 PPP4R3B GUK1 RBM8A DDX24 SYNCRIP HSP90AB1 | 1.35e-04 | 638 | 139 | 14 | int:HNRNPD |
| Interaction | SLFNL1 interactions | 1.41e-04 | 3 | 139 | 2 | int:SLFNL1 | |
| Interaction | CYP4A22 interactions | 1.41e-04 | 3 | 139 | 2 | int:CYP4A22 | |
| Interaction | DPY19L2P4 interactions | 1.41e-04 | 3 | 139 | 2 | int:DPY19L2P4 | |
| Interaction | PTP4A2 interactions | 1.47e-04 | 115 | 139 | 6 | int:PTP4A2 | |
| Interaction | MIR29B1 interactions | 1.50e-04 | 73 | 139 | 5 | int:MIR29B1 | |
| Interaction | PPIE interactions | MCM6 LANCL2 HNRNPF HNRNPH1 YJU2B POLL RBM8A SYNCRIP HSP90AB1 | 1.52e-04 | 282 | 139 | 9 | int:PPIE |
| Interaction | UBL4A interactions | ILF3 SPTAN1 SPTBN1 APP HNRNPF HNRNPH1 HNRNPH2 SYNCRIP HSP90AB1 HSP90AB3P | 1.58e-04 | 349 | 139 | 10 | int:UBL4A |
| Interaction | MCM5 interactions | ILF3 SPTAN1 SPTBN1 MCM6 DBN1 APP TGM3 TIMELESS HERC1 SYNCRIP HSP90AB1 | 1.62e-04 | 420 | 139 | 11 | int:MCM5 |
| Interaction | MIR15A interactions | 1.70e-04 | 75 | 139 | 5 | int:MIR15A | |
| Interaction | TOP3B interactions | EPRS1 FAM193B SPTAN1 POLR2A UBR4 PFAS APP SRCAP DYSF MAST2 MBD3 KMT2C KMT2D FXR1 POLL RBM8A HERC1 CAMSAP1 LSM10 SCARA3 SYNCRIP PCNT TJP3 | 1.77e-04 | 1470 | 139 | 23 | int:TOP3B |
| Interaction | ITGB3 interactions | 1.80e-04 | 170 | 139 | 7 | int:ITGB3 | |
| Interaction | MIR199A2 interactions | 1.81e-04 | 76 | 139 | 5 | int:MIR199A2 | |
| Interaction | MIR7-3 interactions | 1.81e-04 | 76 | 139 | 5 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 1.81e-04 | 76 | 139 | 5 | int:MIR16-1 | |
| Interaction | MIR429 interactions | 1.81e-04 | 76 | 139 | 5 | int:MIR429 | |
| Interaction | CDK7 interactions | STX2 POLR2A SPTBN1 DBN1 APP GRAMD4 HNRNPF HNRNPH1 PCGF6 EXOC6B HSP90AB1 HSP90AB3P | 1.87e-04 | 501 | 139 | 12 | int:CDK7 |
| Interaction | MIR200A interactions | 1.93e-04 | 77 | 139 | 5 | int:MIR200A | |
| Interaction | MIR9-2 interactions | 1.93e-04 | 77 | 139 | 5 | int:MIR9-2 | |
| Interaction | STIP1 interactions | SLC12A6 EPRS1 ILF3 SPTAN1 POLR2A SPTBN1 UBR4 CCT7 MCM6 APP HNRNPF HNRNPH1 TTLL12 FXR1 UMPS SYNCRIP HSP90AB1 HSP90AB3P | 1.95e-04 | 1006 | 139 | 18 | int:STIP1 |
| Interaction | SIRT7 interactions | SPTAN1 POLR2A SPTBN1 UBR4 PFAS MCM6 CHD2 APP HNRNPF TTLL12 TGM3 FXR1 DDX24 SYNCRIP PCNT | 1.96e-04 | 744 | 139 | 15 | int:SIRT7 |
| Interaction | POC1A interactions | 2.03e-04 | 122 | 139 | 6 | int:POC1A | |
| Interaction | MIR92A1 interactions | 2.05e-04 | 78 | 139 | 5 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 2.05e-04 | 78 | 139 | 5 | int:MIR451A | |
| Interaction | MIR98 interactions | 2.05e-04 | 78 | 139 | 5 | int:MIR98 | |
| Interaction | MIR222 interactions | 2.17e-04 | 79 | 139 | 5 | int:MIR222 | |
| Interaction | MIR206 interactions | 2.17e-04 | 79 | 139 | 5 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 2.17e-04 | 79 | 139 | 5 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 2.17e-04 | 79 | 139 | 5 | int:MIR34C | |
| Interaction | PRMT1 interactions | EPRS1 ILF3 SPTAN1 SPTBN1 UBR4 CCT7 DBN1 NCAPH HNRNPF PDCD4 HNRNPH1 HNRNPH2 STAT5A FXR1 RBM8A SYNCRIP HSP90AB1 | 2.29e-04 | 929 | 139 | 17 | int:PRMT1 |
| Interaction | MIR143 interactions | 2.31e-04 | 80 | 139 | 5 | int:MIR143 | |
| Interaction | MIR145 interactions | 2.44e-04 | 81 | 139 | 5 | int:MIR145 | |
| Interaction | AURKB interactions | UBR4 CCT7 DBN1 APP NCAPH MBD3 HNRNPF HNRNPH2 FXR1 TIMELESS CRYBG3 DDX24 SYNCRIP HSP90AB1 HSP90AB3P | 2.50e-04 | 761 | 139 | 15 | int:AURKB |
| Interaction | IQCB1 interactions | EPRS1 STRN3 SPTAN1 SPTBN1 HNRNPF HNRNPH1 HNRNPH2 GUK1 SCARA3 HSP90AB1 | 2.52e-04 | 370 | 139 | 10 | int:IQCB1 |
| Interaction | MIR10B interactions | 2.59e-04 | 82 | 139 | 5 | int:MIR10B | |
| Interaction | STYXL1 interactions | 2.59e-04 | 45 | 139 | 4 | int:STYXL1 | |
| Interaction | CUL4A interactions | MAGEA1 EPRS1 STRN3 CASP14 ANK3 POLR2A UBR4 APP HNRNPF PDCD4 HNRNPH1 TGM3 FXR1 CYB5A KPNA1 HSP90AB1 | 2.72e-04 | 854 | 139 | 16 | int:CUL4A |
| Interaction | MAP1LC3A interactions | 2.73e-04 | 241 | 139 | 8 | int:MAP1LC3A | |
| Interaction | MIR106A interactions | 2.74e-04 | 83 | 139 | 5 | int:MIR106A | |
| Interaction | RSPH10B2 interactions | 2.81e-04 | 4 | 139 | 2 | int:RSPH10B2 | |
| Interaction | CHMP4C interactions | EPRS1 ILF3 CASP14 SPTAN1 SPTBN1 DBN1 HNRNPF HNRNPH1 HNRNPH2 FXR1 RBM8A SYNCRIP HSP90AB1 HSP90AB3P | 2.89e-04 | 687 | 139 | 14 | int:CHMP4C |
| Interaction | MIR199A1 interactions | 2.90e-04 | 84 | 139 | 5 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 2.90e-04 | 84 | 139 | 5 | int:MIR200B | |
| Interaction | MIR31 interactions | 2.90e-04 | 84 | 139 | 5 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 2.90e-04 | 84 | 139 | 5 | int:MIR7-2 | |
| Interaction | PRPF19 interactions | EPRS1 POLR2A UBR4 NCAPH HNRNPF HNRNPH1 PPP4R3B YJU2B RBM8A SYNCRIP KPNA1 | 2.93e-04 | 450 | 139 | 11 | int:PRPF19 |
| Interaction | PSMD14 interactions | ILF3 PLXDC1 SPTBN1 UBR4 CCT7 APP HNRNPH1 HNRNPH2 HERC1 DDX24 PCNT HSP90AB1 | 2.97e-04 | 527 | 139 | 12 | int:PSMD14 |
| Interaction | RBM39 interactions | MAGEA1 EPRS1 ILF3 SPTAN1 POLR2A CCT7 MCM6 DBN1 APP HNRNPF HNRNPH1 HNRNPH2 FXR1 RBM8A PRPF38A DDX24 SYNCRIP HSP90AB1 | 2.99e-04 | 1042 | 139 | 18 | int:RBM39 |
| Interaction | BTRC interactions | ILF3 CASP14 POLR2A CCT7 DBN1 MAST2 MBD3 HNRNPF PDCD4 HNRNPH1 TGM3 FXR1 SYNCRIP KPNA1 HSP90AB1 | 3.03e-04 | 775 | 139 | 15 | int:BTRC |
| Interaction | MIR107 interactions | 3.06e-04 | 85 | 139 | 5 | int:MIR107 | |
| Interaction | MIR18B interactions | 3.06e-04 | 85 | 139 | 5 | int:MIR18B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | NWD1 ILF3 CASP14 ZNF559 CYP4F2 MBD3 YJU2B CYP4F3 CYP4F11 TJP3 | 2.12e-04 | 797 | 143 | 10 | chr19p13 |
| Cytoband | 22q13.31 | 4.07e-04 | 46 | 143 | 3 | 22q13.31 | |
| Cytoband | 2p13.2 | 6.23e-04 | 12 | 143 | 2 | 2p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q25 | 7.78e-04 | 131 | 143 | 4 | chr10q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 9.33e-04 | 61 | 143 | 3 | chr1p33 | |
| Cytoband | 10q25.1 | 1.27e-03 | 17 | 143 | 2 | 10q25.1 | |
| GeneFamily | Cytochrome P450 family 4 | 2.07e-08 | 36 | 89 | 6 | 1003 | |
| GeneFamily | EF-hand domain containing|Spectrins | 4.95e-04 | 7 | 89 | 2 | 1113 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 4.95e-04 | 7 | 89 | 2 | 785 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.96e-06 | 192 | 143 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.51e-06 | 197 | 143 | 7 | fd76cc5e12c7e7943a48f739e4f0626ff7211f51 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.51e-06 | 197 | 143 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-06 | 198 | 143 | 7 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-06 | 198 | 143 | 7 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 3.87e-06 | 200 | 143 | 7 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.66e-06 | 142 | 143 | 6 | d08e1880425d285c4433014fe0242ac7ff7734af | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.14e-05 | 156 | 143 | 6 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.14e-05 | 156 | 143 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 169 | 143 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 174 | 143 | 6 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-05 | 177 | 143 | 6 | b7cfa3776f58377e35830780650d236b5cceecee | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-05 | 177 | 143 | 6 | 1730e640986e50943bd781b7d949bcc5b7c12dde | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.64e-05 | 181 | 143 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.72e-05 | 182 | 143 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.83e-05 | 110 | 143 | 5 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.83e-05 | 110 | 143 | 5 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.83e-05 | 110 | 143 | 5 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.98e-05 | 185 | 143 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 185 | 143 | 6 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.08e-05 | 186 | 143 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.08e-05 | 186 | 143 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.27e-05 | 188 | 143 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.57e-05 | 191 | 143 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.78e-05 | 193 | 143 | 6 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 193 | 143 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.89e-05 | 194 | 143 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-05 | 194 | 143 | 6 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-05 | 194 | 143 | 6 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-05 | 194 | 143 | 6 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 195 | 143 | 6 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 195 | 143 | 6 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.01e-05 | 195 | 143 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 4.01e-05 | 195 | 143 | 6 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | mild-dn_T|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.01e-05 | 195 | 143 | 6 | 158f0f229bad71cc9b06b7399168982bbbbd1d47 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 195 | 143 | 6 | 359b9d791e26844675c3c60cf69d8ab69c2cf400 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.24e-05 | 197 | 143 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.48e-05 | 199 | 143 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.48e-05 | 199 | 143 | 6 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.61e-05 | 200 | 143 | 6 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.65e-05 | 122 | 143 | 5 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-04 | 148 | 143 | 5 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| Drug | nifedipine | CACNA1F ATP7B CYP4A11 MYH7B CYP4F2 APP RYR3 CYP4A22 CYB5B CYP4F3 CYP4F11 EIF2AK3 CYB5A | 1.80e-06 | 415 | 140 | 13 | CID000004485 |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 3.03e-06 | 192 | 140 | 9 | 7104_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.58e-06 | 196 | 140 | 9 | 1684_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.74e-06 | 197 | 140 | 9 | 3620_DN | |
| Drug | chloral hydrate | 1.53e-05 | 129 | 140 | 7 | CID000002707 | |
| Drug | 20-hydroxyleukotriene B4 | 1.84e-05 | 26 | 140 | 4 | CID000001589 | |
| Drug | lansoprazole | 2.39e-05 | 93 | 140 | 6 | CID000003883 | |
| Drug | 18-HETE | 2.65e-05 | 10 | 140 | 3 | CID006442778 | |
| Drug | Iohexol [66108-95-0]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.65e-05 | 193 | 140 | 8 | 3322_DN | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.85e-05 | 195 | 140 | 8 | 5884_UP | |
| Drug | 1-2H | 2.89e-05 | 58 | 140 | 5 | CID000079034 | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; HL60; HT_HG-U133A | 2.96e-05 | 196 | 140 | 8 | 2438_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 5332_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; HL60; HT_HG-U133A | 3.18e-05 | 198 | 140 | 8 | 2526_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.30e-05 | 199 | 140 | 8 | 7367_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 3.42e-05 | 200 | 140 | 8 | 6970_UP | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 3.42e-05 | 200 | 140 | 8 | 7480_UP | |
| Drug | oleocanthal | 3.75e-05 | 2 | 140 | 2 | ctd:C503534 | |
| Drug | N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide | 3.75e-05 | 2 | 140 | 2 | ctd:C503100 | |
| Drug | propoxyphene | 5.82e-05 | 67 | 140 | 5 | CID000010100 | |
| Disease | 1,5 anhydroglucitol measurement | 9.93e-06 | 29 | 138 | 4 | EFO_0008009 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 2.17e-05 | 2 | 138 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Liver carcinoma | MAGEA1 PLXDC1 CYP4A11 CLTRN ESM1 NCAPH KMT2C TGM3 UMPS AADAT | 1.43e-04 | 507 | 138 | 10 | C2239176 |
| Disease | Malignant neoplasm of breast | MAGEA1 ATP7B SPTAN1 UBR4 DBN1 NSMCE2 DYSF PDCD4 FAAH STAT5A KMT2D FXR1 UMPS TIMELESS MMP3 | 1.58e-04 | 1074 | 138 | 15 | C0006142 |
| Disease | neuropeptide W measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0801835 | |
| Disease | X-14939 measurement | 3.22e-04 | 6 | 138 | 2 | EFO_0800747 | |
| Disease | 10-undecenoate 11:1n1 measurement | 4.49e-04 | 7 | 138 | 2 | EFO_0021099 | |
| Disease | octadecanedioylcarnitine (C18-DC) measurement | 4.49e-04 | 7 | 138 | 2 | EFO_0800371 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 5.97e-04 | 8 | 138 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | lactase-phlorizin hydrolase measurement | 5.97e-04 | 8 | 138 | 2 | EFO_0801753 | |
| Disease | neutrophil count, basophil count | 6.69e-04 | 224 | 138 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | diverticulitis | 6.92e-04 | 37 | 138 | 3 | EFO_1001460 | |
| Disease | hypertension (biomarker_via_orthology) | 7.17e-04 | 227 | 138 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | vitamin K measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0004618 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 7.65e-04 | 9 | 138 | 2 | EFO_0800562 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.16e-03 | 11 | 138 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | triacylglycerol 56:2 measurement | 1.16e-03 | 11 | 138 | 2 | EFO_0010429 | |
| Disease | metabolite measurement | 1.32e-03 | 560 | 138 | 9 | EFO_0004725 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.39e-03 | 12 | 138 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.39e-03 | 12 | 138 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 1.58e-03 | 49 | 138 | 3 | EFO_0021897 | |
| Disease | serum metabolite measurement | ABO CYP4A11 CYP4F2 GCH1 HUNK GFUS FAAH TBC1D13 EXOC6B SORCS3 UMPS PCSK9 | 1.65e-03 | 945 | 138 | 12 | EFO_0005653 |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.67e-03 | 50 | 138 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | factor VIII measurement, coronary artery disease | 1.99e-03 | 113 | 138 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Drug habituation | 2.12e-03 | 115 | 138 | 4 | C0013170 | |
| Disease | Drug abuse | 2.12e-03 | 115 | 138 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.12e-03 | 115 | 138 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.12e-03 | 115 | 138 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.12e-03 | 115 | 138 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.12e-03 | 115 | 138 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.12e-03 | 115 | 138 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.12e-03 | 115 | 138 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.12e-03 | 115 | 138 | 4 | C0029231 | |
| Disease | Substance abuse problem | 2.19e-03 | 116 | 138 | 4 | C0740858 | |
| Disease | unipolar depression, autism spectrum disorder | 2.19e-03 | 15 | 138 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.33e-03 | 118 | 138 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | disease progression measurement | 2.95e-03 | 61 | 138 | 3 | EFO_0008336 | |
| Disease | Coronary Arteriosclerosis | 3.54e-03 | 65 | 138 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 3.54e-03 | 65 | 138 | 3 | C1956346 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 3.69e-03 | 66 | 138 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.19e-03 | 69 | 138 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Nonorganic psychosis | 4.19e-03 | 69 | 138 | 3 | C0349204 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.30e-03 | 21 | 138 | 2 | EFO_0022246 | |
| Disease | Malignant neoplasm of liver | 4.52e-03 | 142 | 138 | 4 | C0345904 | |
| Disease | Liver neoplasms | 4.52e-03 | 142 | 138 | 4 | C0023903 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.54e-03 | 71 | 138 | 3 | EFO_0001645, EFO_0004791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YDHSEEGLMASIERE | 141 | Q717R9 | |
| GEEGFMAHVDRVIDF | 311 | Q8N5Z0 | |
| MDQFGDILEGEVDHS | 1 | Q9P2B7 | |
| EDDADKMHVDREFAV | 246 | Q9NXR5 | |
| DVDMEFRDHVGVEIL | 211 | P16442 | |
| LEEDHGLFEISTAEM | 2446 | Q68DQ2 | |
| LEFSGMDHEDISESV | 741 | Q9NZJ5 | |
| ISEVKMDAEFRHDSG | 666 | P05067 | |
| DLRDHVNDMGFEAAI | 196 | P35670 | |
| ERMEKRDGSEEDFHL | 276 | Q6UXU4 | |
| LVFGAMVHRDEAFET | 546 | Q6IC98 | |
| LRAEVDTFMFEGHDT | 311 | Q02928 | |
| LMEFVEGTEHDVDLV | 601 | A5YM72 | |
| DVVDIEEAEHDFMGE | 741 | Q5T5Y3 | |
| EEAEHDFMGEAHPVV | 746 | Q5T5Y3 | |
| DAHRESMEGFRIEME | 786 | Q8NB25 | |
| THIVVDEGMDYERAL | 81 | Q9UGP5 | |
| EHEDMVETAVFGTEN | 1126 | Q149M9 | |
| EHIVVRSLEEDMFDG | 61 | Q9HBI0 | |
| AITVIGHMDFEESRA | 301 | Q9Y5H5 | |
| MADVLDLHEAGGEDF | 1 | Q9Y5S9 | |
| RDTDMEVEDFIGVDS | 181 | Q8IWB1 | |
| VGAAVFDALESDHEM | 21 | Q9NPC2 | |
| EEERVFFMDDVEGTA | 396 | Q9HCC9 | |
| DDAETAEMIAHRTGG | 496 | Q9HCC9 | |
| AITVIGHMDFEESRA | 301 | Q9UN72 | |
| RFDEEDLGDEMACVH | 1961 | O60840 | |
| MPEEVHHGEEEVETF | 1 | P08238 | |
| DEESHEFVIEAGALM | 436 | Q14566 | |
| EHSRDGEMDDSREGE | 1226 | Q8NEZ4 | |
| ESVAHGRIDNVDAFM | 36 | Q969L4 | |
| HKEMTFIFTDGEDEA | 141 | Q8NES3 | |
| EELSVMEVYDGREHS | 216 | P43355 | |
| DMLAHVEELARDGEA | 246 | O95983 | |
| AAAFHEEFVVREDLM | 216 | P51114 | |
| MPEEVHHGEEEVETF | 1 | Q58FF7 | |
| FEEMERDFQGVLHEL | 16 | Q5T655 | |
| QDEAEASMEALREAH | 56 | Q9ULE4 | |
| HSFTRTIDEEAEMEE | 1341 | Q15751 | |
| AEMEEQAERDREEGH | 1351 | Q15751 | |
| EADIMISFAVREHGD | 156 | P08254 | |
| LHLGGEAEMEERAFV | 11 | Q9NS86 | |
| IHFDERDGAVKAMEE | 376 | O60506 | |
| ADVEFATHEDAVAAM | 331 | P55795 | |
| ATDHAMDILGFSVDE | 376 | A7E2Y1 | |
| SDHREIEGRVMVTDF | 191 | Q8NBP7 | |
| FEHGDTNEVAEMLRD | 176 | Q53EL6 | |
| ASFMDAGVEHDDVAE | 536 | Q9BUK6 | |
| GHTYEEDAIVRMIES | 186 | Q96MF7 | |
| TVDDDVAEGTMVGDH | 791 | Q9Y4C0 | |
| ENFEDVGHSTDAREM | 61 | P00167 | |
| AEAVVEAMDFHGEVT | 256 | Q13630 | |
| IFGDHRDEEEETHMK | 256 | Q16643 | |
| MAEAESLETAAEHER | 6 | Q9Y2D4 | |
| ADVEFATHEDAVAAM | 331 | P31943 | |
| ESEEERFEEMPETSH | 116 | Q5MIZ7 | |
| MDEQAAEREHEREEF | 1481 | O95613 | |
| GFTEHIEDVKMAFDR | 316 | P52757 | |
| AERIMVEGFHVDDKT | 226 | P20848 | |
| MVEDGAEELEDLVHF | 1 | O94889 | |
| MQRDIAAGDFIEHAE | 61 | Q16774 | |
| EVRFLTHMDEEDQSD | 2766 | Q9H799 | |
| FATMEDEEELEERPH | 1026 | O14647 | |
| SMEEDERQTGREHAV | 136 | Q96PV7 | |
| EDIRAEADTFMFEGH | 316 | Q9HBI6 | |
| LRAEVDTFMFEGHDT | 311 | Q5TCH4 | |
| FEAMEELDGDDVRVS | 466 | Q8IYJ1 | |
| ESFEDVGHSSDAREM | 76 | O43169 | |
| VGHMDLREEGDEETT | 51 | Q9NPF7 | |
| ETGGSHDKRFVMEVE | 546 | Q12906 | |
| LDMVRSFESVDRDDH | 556 | P57058 | |
| EGASERIEETMSVHD | 2261 | Q12955 | |
| HEDIREEVDTFMFEG | 316 | Q6ZWL3 | |
| EDIRAEADTFMFEGH | 316 | P78329 | |
| LHMLEDFVDSFTEDA | 196 | Q9Y6X4 | |
| DAHERSESSEVAFVM | 396 | Q6P0Q8 | |
| FRMEGVSEDLDEIHL | 66 | Q8NHY5 | |
| DIFDAIVMADERFHG | 6 | Q8WV07 | |
| DEADRMVEKGHFAEL | 471 | Q9GZR7 | |
| EHDMASGDGNIVREE | 151 | Q9NQ30 | |
| MEEDQEELIFGHGDT | 101 | Q4VXA5 | |
| FHMEEDQEELIFGLD | 26 | Q5JSQ8 | |
| EDIRAEADTFMFEGH | 316 | Q08477 | |
| LSDIDHDGMLDRDEF | 171 | P42566 | |
| TVTAEDEAQMEHYRG | 511 | O00519 | |
| GSEEDLDALEHMFRQ | 31 | P31944 | |
| AEVEVVEMHDSDISA | 971 | Q9UHW9 | |
| ERFESLEGRMASHEI | 341 | Q6AZY7 | |
| DMDAGHLSFVEEVFE | 941 | O75923 | |
| ADMLVHDFDDERTLE | 26 | Q8N108 | |
| EEEEDMSHFSLRLEG | 96 | Q9BYE7 | |
| DRVDHMFTSEFDAEV | 1006 | Q9Y6R4 | |
| EELHRFSDEGMEVIE | 356 | Q15406 | |
| TEVHEGRADIMIDFA | 146 | P24347 | |
| ADVEFATHEEAVAAM | 331 | P52597 | |
| APRTHETFHEEEEDM | 1066 | Q9NQT8 | |
| AAEEEDAIHALFGSM | 236 | Q6ZRF8 | |
| TRMTDHEGARAEEAE | 401 | Q13033 | |
| EGHSAFATMEEAAEE | 1171 | P07814 | |
| DGEMEHSAALRQEVD | 496 | Q8TEQ0 | |
| EADLVHMEVRTTDGY | 351 | Q9UPU3 | |
| ETEEEVMSDGGFHEA | 56 | P52294 | |
| VLNDAIFDEDHDEMV | 116 | P30793 | |
| MAEEGDVDEADVFLA | 1 | Q5STR5 | |
| GGAEQFMEETERSLH | 376 | Q99832 | |
| TGSEDMCVHFFDVER | 426 | Q9H1Z4 | |
| EVDHAMELSELAREG | 426 | Q6ZRS2 | |
| DGDTVVVVEKDHFMD | 16 | P32856 | |
| GEDMIAEEHFGSEKI | 701 | Q01082 | |
| EFDLDETMDVARHVE | 751 | P42229 | |
| VDSVFMGNHAEREEY | 141 | Q08188 | |
| NRMFEVIGETLEHDF | 671 | Q8TDI8 | |
| VRFIADHMRSEDDDQ | 431 | P17787 | |
| VALEDEMDADPSFHD | 451 | O94911 | |
| AFIMEDLEDVALDHV | 141 | Q495B1 | |
| EEVEGHVADGSATEM | 191 | Q15003 | |
| MGAAHSASEEVRELE | 1 | Q96BS2 | |
| GHINDAFMTEDERLT | 206 | Q9HBJ8 | |
| ELAFTQEEMTDFEEH | 861 | Q9NRU3 | |
| LAEDVFVHVDMSEGV | 256 | Q5JTD0 | |
| FEEFRDSDDVLGHIM | 901 | Q9UNS1 | |
| EMEREYEVDHEGKAS | 1441 | Q86UP3 | |
| EMRTEDERVTNHEDG | 771 | O15394 | |
| EEEFQKHEGMSERER | 146 | Q5EBL4 | |
| FGIHDDTMEAERAEV | 4241 | Q15413 | |
| ESQDGVDHFRAMIVE | 721 | P38935 | |
| MDEEDDGSRIREHEL | 856 | Q5TF21 | |
| DEEEVVHVDRDHFMD | 16 | P61266 | |
| DHFMDEFFEQVEEIR | 26 | P61266 | |
| FDEHMVELIVGSSED | 181 | Q8WZ04 | |
| FEEFQTDMAAHEERV | 191 | Q13813 | |
| DREMADAFHLAGFEV | 1076 | O15067 | |
| SFEETVDVLMEAAAH | 1431 | P24928 | |
| AVRMAEEHSEFVVGF | 386 | P11172 | |
| ANMGVSREDVTFEDH | 86 | Q9NVG8 | |
| NGEFELMHVDEFIDE | 136 | Q8NAV1 | |
| LETDAMFRLEHGEAD | 141 | P13994 | |
| LEHEVFDAGEVFGIM | 56 | Q14166 | |
| KFMRVHDAESSDEDG | 896 | O95049 | |
| GEQEDAHEFLMFTVD | 156 | P0C7H9 | |
| AEGRMCEDFQDEDHD | 351 | Q8IUK5 | |
| HESGRREIEMFDSAI | 411 | Q658N2 | |
| RDFMEDDHERAVSVT | 401 | Q8IWV8 | |
| EVDHGDFEMVSESMV | 2761 | Q5T4S7 | |
| SSVVEMERNHFGEEL | 76 | Q9BR84 | |
| FHSEMEGEDTRDDSL | 111 | P51508 | |
| EFEEMLEHAESAQDF | 226 | Q96GC9 | |
| VVGVSDEAELHEMET | 1061 | O14686 |